Literature DB >> 27239137

Diagnostic value of occult fecal blood testing for colorectal cancer screening.

K Chen1, D A Jiao1, S Zheng1, L Zhou1, H Yu1, Y C Yuan1, K Y Yao1, X Y Ma1, Y Zhang1.   

Abstract

AIM: To evaluate the diagnostic value of occult fecal blood testing in mass colorectal cancer screening.
METHODS: A reverse passive hemagglutination reaction fecal occult blood test (RPHA-FOBT) and colorectal cancer risk factor quantitative method were used as preliminary screening for colorectal cancer. A 60-cm fiber optic colonoscopy was used to validate the preliminary screen and was used to detect colorectal cancer in a community of 75813 subjects.
RESULTS: Compared to the 60-cm fiber optic colonoscopy as a standard reference, FOBT has a sensitivity of 41.9%, specificity of 95.8%, Youden's index of 0.38, and positive predictive value of 0.68%. These results increased with subject age from the first detection. A 3-year follow up in the target mass showed that all new cases had initially been FOBT-negative.
CONCLUSION: The value of FOBT as an indicator of colorectal cancer in mass screening is limited.

Entities:  

Keywords:  Colonoscopy; Colorectal neoplasms/diagnosis; Mass screening; Occult blood; Risk factors

Year:  1997        PMID: 27239137      PMCID: PMC4842878          DOI: 10.3748/wjg.v3.i3.166

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  11 in total

Review 1.  The prospects for mass population screening in colorectal cancer.

Authors:  J D Hardcastle
Journal:  Cancer Surv       Date:  1989

2.  [Evaluation of RPHA fecal occult blood test in screening for colorectal cancer].

Authors:  H Yu
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  1990-03

3.  Detecting colorectal cancer with a large scale fecal occult blood testing program.

Authors:  D I Gregorio; P Lolachi; H Hansen
Journal:  Public Health Rep       Date:  1992 May-Jun       Impact factor: 2.792

4.  [Experimental study on reverse passive hemagglutination for the detection of human fecal occult blood].

Authors:  P H Zhou; W Z Zhang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  1987-12

5.  [An applied study on the method of multi-factorial quantitative-risk assessment (MFQRA) for mass screening of colorectal cancer].

Authors:  K Chen
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  1993-01

6.  [Study of Dukes' staging of colorectal carcinoma by the prognosis. National Cooperative Group on Pathology and Prognosis of Colorectal Cancer].

Authors: 
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  1986-03

7.  Mass screening for colorectal cancer.

Authors:  I T Khubchandani; M C Karamchandani; F S Kleckner; J A Sheets; J J Stasik; L Rosen; R D Riether
Journal:  Dis Colon Rectum       Date:  1989-09       Impact factor: 4.585

8.  Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects.

Authors:  J D Hardcastle; W M Thomas; J Chamberlain; G Pye; J Sheffield; P D James; T W Balfour; S S Amar; N C Armitage; S M Moss
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

9.  Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects.

Authors:  J Kewenter; S Björk; E Haglind; L Smith; J Svanvik; C Ahrén
Journal:  Cancer       Date:  1988-08-01       Impact factor: 6.860

Review 10.  Occult blood screening for colorectal carcinoma: a critical review.

Authors:  J B Simon
Journal:  Gastroenterology       Date:  1985-03       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.